Differential metabolism of 4-hydroxynonenal in liver, lung and brain of mice and rats.
Ruijin Zheng, Ana-Cristina Dragomir, Vladimir Mishin, Jason R Richardson, Diane E Heck, Debra L Laskin, Jeffrey D Laskin
Index: Toxicol. Appl. Pharmacol. 279(1) , 43-52, (2014)
Full Text: HTML
Abstract
The lipid peroxidation end-product 4-hydroxynonenal (4-HNE) is generated in tissues during oxidative stress. As a reactive aldehyde, it forms Michael adducts with nucleophiles, a process that disrupts cellular functioning. Liver, lung and brain are highly sensitive to xenobiotic-induced oxidative stress and readily generate 4-HNE. In the present studies, we compared 4-HNE metabolism in these tissues, a process that protects against tissue injury. 4-HNE was degraded slowly in total homogenates and S9 fractions of mouse liver, lung and brain. In liver, but not lung or brain, NAD(P)+ and NAD(P)H markedly stimulated 4-HNE metabolism. Similar results were observed in rat S9 fractions from these tissues. In liver, lung and brain S9 fractions, 4-HNE formed protein adducts. When NADH was used to stimulate 4-HNE metabolism, the formation of protein adducts was suppressed in liver, but not lung or brain. In both mouse and rat tissues, 4-HNE was also metabolized by glutathione S-transferases. The greatest activity was noted in livers of mice and in lungs of rats; relatively low glutathione S-transferase activity was detected in brain. In mouse hepatocytes, 4-HNE was rapidly taken up and metabolized. Simultaneously, 4-HNE-protein adducts were formed, suggesting that 4-HNE metabolism in intact cells does not prevent protein modifications. These data demonstrate that, in contrast to liver, lung and brain have a limited capacity to metabolize 4-HNE. The persistence of 4-HNE in these tissues may increase the likelihood of tissue injury during oxidative stress. Copyright © 2014 Elsevier Inc. All rights reserved.
Related Compounds
Related Articles:
Effects of fluoride and ethanol administration on lipid peroxidation systems in rat brain.
2013-03-01
[Indian J. Exp. Biol. 51(3) , 249-55, (2013)]
Ameliorative effect of mepenzolate bromide against pulmonary fibrosis.
2014-07-01
[J. Pharmacol. Exp. Ther. 350(1) , 79-88, (2014)]
2013-07-01
[Br. J. Haematol. 162(1) , 135-7, (2013)]
2014-09-02
[Toxicology 323 , 61-9, (2014)]
2013-06-13
[J. Med. Chem. 56(11) , 4641-55, (2013)]